The Effect of PEG Use Education on the Care Burden and Quality of Life of Patients' Relatives
Launched by ULUDAG UNIVERSITY · Jul 12, 2025
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how teaching family members to use a feeding tube called a PEG (Percutaneous Endoscopic Gastrostomy) before a patient leaves the hospital affects the stress and quality of life of those who care for palliative care patients. Palliative care means care focused on comfort for people with serious illnesses. The study wants to see if this training helps caregivers feel more confident and less overwhelmed while improving their overall well-being.
To take part, caregivers need to be adults who are primarily responsible for a patient over 18 who receives palliative care and uses a PEG feeding tube, especially if the patient had a stroke at least six months ago. Caregivers also need to be mentally and emotionally ready to provide care and not have serious health or mental health issues. Participants will have face-to-face interviews at the start, after one month, and after three months. Only the group receiving the training will get education about PEG use at the first meeting. During the study, caregivers will fill out simple questionnaires about their stress, burden, and quality of life. This study aims to help families better manage care and improve their daily lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The caregiver must be over 18 years old
- • The caregiver must be willing and able to participate in the study
- • The caregiver must be primarily responsible for the patient's care
- • The patient they are caring for must be receiving palliative care
- • The patient they are caring for must be receiving PEG feeding
- • The patient they are caring for must be over 18 years old
- • The patient they are caring for must have been diagnosed with stroke at least six months ago
- • The caregiver must have a mini mental test score of 25 points or more
- • The Beck depression scale score must be under 17 points
- • The caregiver must have a score of over 16 points on the Readiness to Provide Care Scale
- Exclusion Criteria:
- • The caregiver is under the age of 18
- • The caregiver is not willing and able to participate in the research
- • The caregiver has a physical disability or serious health problem that makes it difficult to provide care
- • The patient they are caring for is under the age of 18
- • The patient they are caring for has been diagnosed with cancer, endocrine system or GI disease
- • The caregiver has a mini mental test score of less than 25
- • The Beck depression scale score is 17 points or higher
- • The caregiver has scored 16 or lower on the Readiness to Provide Care Scale
- • The caregiver has communication problems
- • The caregiver has been diagnosed with depression or psychiatric disorder
- • The caregiver is receiving psychotherapy/psychological support
- • The caregiver is taking antidepressants and/or anxiolytics
- • The caregiver has sensory loss related to vision and hearing
About Uludag University
Uludağ University is a leading academic institution located in Bursa, Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Uludağ University leverages its extensive expertise and resources to facilitate innovative research initiatives aimed at improving healthcare outcomes. The university's collaborative approach fosters partnerships with healthcare professionals, researchers, and industry stakeholders, ensuring rigorous adherence to ethical standards and regulatory guidelines. Through its clinical trials, Uludağ University aims to contribute significantly to the scientific community and enhance the understanding of various medical conditions and treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
İstanbul, , Turkey
Patients applied
Trial Officials
Hicran Yıldız, Prof.Dr.
Principal Investigator
Bursa Uludag Unversity
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported